Citation: D. Serin et al., PARCOURS DE FEMMES - A SURVEY OF OPINIONS OF FRENCH WOMEN WITH CANCER- THE FIRST STEP OF A PAN-EUROPEAN SURVEY IN 16 COUNTRIES, European journal of cancer, 34, 1998, pp. 280-280
Authors:
CULINE S
FABBRO M
YCHOU M
ROMIEU G
CUPISSOL D
PUJOL H
Citation: S. Culine et al., CHEMOTHERAPY IN CARCINOMAS OF UNKNOWN PRIMARY SITE (CUP) - A HIGH-DOSE INTENSITY POLICY, Annals of oncology, 9, 1998, pp. 231-231
Citation: Jm. Gastaud et al., IN-VITRO ANTIPROLIFERATIVE EFFECT OF HALO GENIC QUATERNARY AMMONIUM ON TUMOR-CELLS, Comptes rendus de l'Academie des sciences. Serie 3, Sciences de la vie, 321(1), 1998, pp. 5-10
Citation: D. Serin et al., PARCOURS-DE-FEMMES - A FRENCH OPINION SURVEY ON PSYCHOLOGICAL-ASPECTSAND FEELINGS OF 2,874 PATIENTS TREATED FOR BREAST OR GYNECOLOGICAL CANCER AND OF THEIR MEDICAL ONCOLOGICAL TEAMS, Bulletin du cancer, 85(6), 1998, pp. 578-588
Authors:
CULINE S
FABBRO M
ASSENS C
YCHOU M
ROMIEU G
KRAMAR A
CUPISSOL D
PINGUET F
PUJOL H
Citation: S. Culine et al., 4-STEP HIGH-DOSE SEQUENTIAL CHEMOTHERAPY WITH HEMATOPOIETIC PROGENITOR-CELL SUPPORT AS INDUCTION TREATMENT FOR PATIENTS WITH SOLID TUMORS, Annals of oncology, 8(10), 1997, pp. 951-956
Citation: Mm. Melhouf et al., LEIOMYOSARCOMA OF THE SMALL-BOWEL - 2 NEW CASES, Annales de Gastroenterologie et d'Hepatologie, 33(5-6), 1997, pp. 227-229
Authors:
FERRIERES G
CUNY M
SIMONYLAFONTAINE J
JACQUEMIER J
ROULEAU C
GUILLEUX F
GRENIER J
ROUANET P
PUJOL H
JEANTEUR P
ESCOT C
Citation: G. Ferrieres et al., VARIATION OF BCL-2 EXPRESSION IN BREAST DUCTS AND LOBULES IN RELATIONTO PLASMA PROGESTERONE LEVELS - OVEREXPRESSION AND ABSENCE OF VARIATION IN FIBROADENOMAS, Journal of pathology, 183(2), 1997, pp. 204-211
Authors:
YCHOU M
ASTRE C
ROUANET P
FABRE JM
SAINTAUBERT B
DOMERGUE J
RIBARD D
CIURANA AJ
JANBON C
PUJOL H
Citation: M. Ychou et al., A PHASE-II STUDY OF 5-FLUOROURACIL, LEUCOVORIN AND CISPLATIN (FLP) FOR METASTATIC GASTRIC-CANCER, European journal of cancer, 32A(11), 1996, pp. 1933-1937
Citation: H. Pujol, 20 YEARS OF CANCER-EPIDEMIOLOGY - THE CLI NICIAN POINT-OF-VIEW, Revue d'epidemiologie et de sante publique, 44(6), 1996, pp. 540-546
Authors:
GERBER M
ASTRE C
SEGALA C
SAINTOT M
SCALI J
SIMONYLAFONTAINE J
GRENIER J
PUJOL H
Citation: M. Gerber et al., OXIDANT ANTIOXIDANT STATUS ALTERATIONS IN CANCER-PATIENTS - RELATIONSHIP TO TUMOR PROGRESSION, The Journal of nutrition, 126(4), 1996, pp. 1201-1207
Authors:
PUJOL H
GIRAULT J
ROUANET P
FOURNIER S
GRENIER J
SIMONY J
FOURTILLAN JB
PUJOL JL
Citation: H. Pujol et al., PHASE-I STUDY OF PERCUTANEOUS 4-HYDROXY-TAMOXIFEN WITH ANALYSES OF 4-HYDROXY-TAMOXIFEN CONCENTRATIONS IN BREAST-CANCER AND NORMAL BREAST-TISSUE, Cancer chemotherapy and pharmacology, 36(6), 1995, pp. 493-498
Authors:
ROUANET P
FABRE JM
TICA V
ANAF V
JOZWICK M
PUJOL H
Citation: P. Rouanet et al., CHEST-WALL RECONSTRUCTION FOR RADIONECROSIS AFTER BREAST-CARCINOMA THERAPY, Annals of plastic surgery, 34(5), 1995, pp. 465-470
Citation: H. Pujol, FOUNDATION FOR THE FUTURE OF APPLIED MEDI CAL-RESEARCH - ANXIETY AND INSOMNIA - TOWARDS BETTER PRESCRIPTIONS - (MONTPELLIER, NOVEMBER, 10, 11 AND 12, 1994) - ABSTRACTS, La Semaine des hopitaux de Paris, 71(27-28), 1995, pp. 833-839
Authors:
EISINGER F
LAFFARGUE F
MARANINCHI D
MAUVAISJARVIS P
MOATTI JP
NAMER M
PUJOL H
PHILIP T
SANCHOGARNIER H
Citation: F. Eisinger et al., RECOMMENDATIONS OF THE FEDERATION OF FREN CH CANCER CENTERS ABOUT ESSAYS WITH TAMOXIFEN IN BREAST-CANCER FNCLCC, Bulletin du cancer, 82, 1995, pp. 237-238